Factiva filters

Is Credit Suisse a boost to UBS’s investment banking ambitions?

Is Credit Suisse a boost to UBS’s investment banking ambitions?

A year ago, the world of investment banking suffered its biggest shakeup since the financial crisis with the bailout acquisition of Credit Suisse by UBS. Twelve months on, the long-term impact of the deal is becoming a little clearer – but only a little. Big questions remain, especially for the combined investment banking business. One …

Is Credit Suisse a boost to UBS’s investment banking ambitions? Read More »

Stocks vs. Bonds: A $10 Million+ Investment Decision

Stocks vs. Bonds: A $10 Million+ Investment Decision

Stocks or bonds? Choose wisely. You might think I’m exaggerating by suggesting that this major investment decision is worth more than $10 million, but I’m not. I’ll show you the data, although of course I hope you don’t immediately start planning your expenses. Many investors believe that their financial future will be better if they …

Stocks vs. Bonds: A $10 Million+ Investment Decision Read More »

Amer Sports shares fall 6% on bigger-than-expected Q4 loss

Amer Sports shares fall 6% on bigger-than-expected Q4 loss

Posted: March 5, 2024 at 8:30 am ET Shares of Amer Sports Inc. fell 6% in premarket trade on Tuesday after the Finnish sportswear company reported its first quarterly results since its February IPO. The company, which includes the Arc’teryx, Salomon and Wilson brands, reported better-than-expected fourth-quarter revenue boosted by China and a bigger-than-expected loss. …

Amer Sports shares fall 6% on bigger-than-expected Q4 loss Read More »

This biotech ETF sees a “breakout” while US small-cap tech stocks lag

This biotech ETF sees a “breakout” while US small-cap tech stocks lag

Hello! This week’s ETF Wrap looks at the surge in biotech funds, as well as an “unusual” trend in U.S. small-cap stocks versus small-cap tech stocks. Please send feedback and advice to [email protected] or [email protected]. You can also follow me on X at @cidzelis and found me on LinkedIn. Isabel Wang is on @Isabelxwang. register …

This biotech ETF sees a “breakout” while US small-cap tech stocks lag Read More »

This biotech ETF sees a “breakout” while US small-cap tech stocks lag

This biotech ETF sees a “breakout” while US small-cap tech stocks lag

Hello! This week’s ETF Wrap looks at the surge in biotech funds, as well as an “unusual” trend in U.S. small-cap stocks versus small-cap tech stocks. Please send feedback and advice to [email protected] or [email protected]. You can also follow me on X at @cidzelis and found me on LinkedIn. Isabel Wang is on @Isabelxwang. register …

This biotech ETF sees a “breakout” while US small-cap tech stocks lag Read More »

Car prices are finally coming down.  It looks like a buyer’s market.

Car prices are finally coming down. It looks like a buyer’s market.

The high cost of new cars has been a concern among buyers and investors in the automotive sector for several years since Covid-19 ravaged the global economy. But now a change is happening. New cars are becoming more affordable—and that’s a good thing for car buyers. This is good even for car investors who tend …

Car prices are finally coming down. It looks like a buyer’s market. Read More »

New cars are becoming more affordable.  That’s good for buyers and auto stocks.

New cars are becoming more affordable. That’s good for buyers and auto stocks.

The high cost of new cars has been a concern among buyers and investors in the automotive sector for several years since Covid-19 ravaged the global economy. But now a change is happening. New cars are becoming more affordable — and that’s a good thing for car buyers. This is good even for car investors …

New cars are becoming more affordable. That’s good for buyers and auto stocks. Read More »

The sale price of insurance-brokerage unit Truist is better than expected

The sale price of insurance-brokerage unit Truist is better than expected

The plan of Truist Financial Corp. to sell its remaining stake in Truist Insurance Holdings for $15.5 billion marks a better-than-expected price for the business, an analyst said Tuesday. Citigroup’s Keith Horowitz reiterated a buy rating on Truist and said that while the sale of Truist Insurance Holdings was not a surprise, he had expected …

The sale price of insurance-brokerage unit Truist is better than expected Read More »